CIK 0001472091 · Non-accelerated filer<br>Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264231384
- Phone
- 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-04 | Boesgaard Lars Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-07-14 | Freitag Gregory Gene Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | BRAWLEY OTIS W Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | Ali-Jackson Kamil Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | SYKES RICHARD Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | Iliev Ilian Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-01-05 | Brown Spencer D. Senior VP, General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2023-01-05 | HILL MATTHEW C Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +161,200 | 161,200 | ||
| 2023-01-05 | CONN GREGORY Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +137,200 | 137,200 | ||
| 2023-01-05 | BEDU-ADDO FRANK President/CEO | Grant or award · Employee Stock Option (Right to Buy) | +385,300 | 385,300 | ||
| 2023-01-05 | WOOD LAUREN Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +110,800 | 110,800 | ||
| 2022-12-02 | BEDU-ADDO FRANK President/CEO | Option exercise | +219,535 | $6.57 | $1.4M | 866,050 |
| 2022-12-02 | BEDU-ADDO FRANK President/CEO | Shares withheld for taxes | −175,184 | $9.78 | $1.7M | 690,866 |
| 2022-12-02 | BEDU-ADDO FRANK President/CEO | Option exercise · Stock Option (Right to Buy) | −219,535 | 0 | ||
| 2022-06-28 | Glover Steve C Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2022-06-28 | Iliev Ilian Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2022-06-28 | BRAWLEY OTIS W Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2022-06-28 | SYKES RICHARD Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2022-06-28 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 |
Page 3 of 6 · 118 trades